- /
- Supported exchanges
- / US
- / AEMD.NASDAQ
Aethlon Medical Inc (AEMD NASDAQ) stock market data APIs
Aethlon Medical Inc Financial Data Overview
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Aethlon Medical Inc data using free add-ons & libraries
Get Aethlon Medical Inc Fundamental Data
Aethlon Medical Inc Fundamental data includes:
- Net Revenue: 574 K
- EBITDA: -6 766 567
- Earnings Per Share: -13
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-13
- EPS/Forecast: -4.05
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Aethlon Medical Inc News
New
North Immunology joins biotech reverse merger boom with Aethlon deal
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Dive Brief: North Immunology, in the early stages of...
Aethlon Medical to merge with North Immunology in all-stock deal
Aethlon Medical (AEMD [https://seekingalpha.com/symbol/AEMD]) shares soared 346% premarket on Thursday as it agreed on an all-stock merger with North Immunology. The transaction, approved by both boa...
Aethlon outlines Cohort 3 expansion to 3–6 patients as Hemopurifier oncology trial advances
Earnings Call Insights: Aethlon Medical (AEMD) Q4 2026 MANAGEMENT VIEW * "Now I would like to begin by highlighting progress during the fiscal year ended March 31 going on through the first part o...
Quant snapshot: United Natural Foods, Designer Brands lead top-rated names as MIND Technology, BARK lag
Quant rankings for the upcoming earnings calendar show strength concentrated in consumer staples and consumer discretionary segments, while weakness is more pronounced across consumer-facing and selec...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.